253 related articles for article (PubMed ID: 21565949)
1. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
4. Current treatment of Crimean-Congo hemorrhagic fever in children.
Mardani M; Rahnavardi M; Sharifi-Mood B
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):911-8. PubMed ID: 20695747
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
6. Erythema nodosum in the course of Crimean-Congo haemorrhagic fever.
Bijani B; Mardani M; Toosi P
Trop Doct; 2010 Apr; 40(2):123-4. PubMed ID: 20305115
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
[No Abstract] [Full Text] [Related]
8. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
[TBL] [Abstract][Full Text] [Related]
11. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
Bajpai S; Nadkar MY
J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
[TBL] [Abstract][Full Text] [Related]
12. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
13. Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child.
Saijo M; Tang Q; Shimayi B; Han L; Zhang Y; Asiguma M; Tianshu D; Maeda A; Kurane I; Morikawa S
Jpn J Infect Dis; 2004 Apr; 57(2):55-7. PubMed ID: 15118210
[TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations.
Arda B; Aciduman A; Johnston JC
J Med Ethics; 2012 Feb; 38(2):117-20. PubMed ID: 21994465
[TBL] [Abstract][Full Text] [Related]
16. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial outbreak of Crimean-Congo haemorrhagic fever.
Naderi HR; Sarvghad MR; Bojdy A; Hadizadeh MR; Sadeghi R; Sheybani F
Epidemiol Infect; 2011 Jun; 139(6):862-6. PubMed ID: 20800007
[TBL] [Abstract][Full Text] [Related]
18. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
